Table 2

KRASmutation frequency in the investigated subcohort (KRASWild type: 128 (63.7%),KRASMutation 73 (36.3%))
relative frequency of occurrence (%) absolute frequency of occurrence
CODON 12 mutation:
Aspartate (G12D) c.35G>A 12,4 25
Valine (G12V) c.35G>T 6,5 13
Alanine (G12A) c.35G>C 3,4 7
Cysteine (G12C) c.34G>T 3 6
Serine (G12S) c.34G>A 3 6
Arginine (G12R) c.34G>C 0,5 1
CODON 13 mutation:
Aspartate (G13D) c.38G>A 7,5 15

Reinacher-Schick et al.

Reinacher-Schick et al. BMC Cancer 2012 12:349   doi:10.1186/1471-2407-12-349

Open Data